FDA grants final approval to Mylan Modafinil tablets ANDA
05:18 EDT 13 Aug 2012 | Pharmaceutical Business Review
The US Food and Drug Administration (FDA) has granted final approval to Mylan Pharmaceuticals' abbreviated new drug application (ANDA) of Modafinil tablets USP,100 mg and 200 mg.
Original Article: FDA grants final approval to Mylan Modafinil tablets ANDA
More From BioPortfolio on "FDA grants final approval to Mylan Modafinil tablets ANDA"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
